Bionaut Labs, with a valuation of $70 million, is raising funds on OurCrowd through Reg D 506(c) raise. The company is reimagining therapeutics with its precision-targeted medicine and micro-robots. The micro-robot Bionauts are injected into the cerebrospinal fluid and guided magnetically to precise locations within the central nervous system. These Bionauts help in gene therapy, diagnostic payload, and other medications. Michael Shpigelmacher and Aviad Maizels founded Bionaut Labs in 2016. The current crowdfunding campaign has a minimum target of $10,000 and a maximum target of $5,550,000. The campaign proceeds will be used for growth and expansion.